SEC Form 4 · accession 0001179110-15-009071
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — Chairman & CEO · Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 16,667 | $18.27 | A | 341,143 | D | |
| Common StockF1,F2 | Jun 1, 2015 | S | 16,667 | $28.1059 | D | 324,476 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F4,F3 | $18.27 | Jun 1, 2015 | M | 16,667 | D | — | Nov 30, 2015 | Common Stock | 16,667 | 83,332 | D |
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $27.61 to a high of $28.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This option vested in forty-eight equal installments beginning on December 30, 2005.
- F4Not applicable.